Shahedur Rahman
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Shahedur Rahman's research focuses on the development of novel nanomedicines for cancer therapy. His work involves creating ionic nanomedicines that are responsive to near-infrared light, utilizing macrocyclic histone deacetylase inhibitors. This approach aims to enhance the efficacy of cancer treatment by enabling targeted drug delivery and activation within tumor cells. Rahman has collaborated with researchers Nawab Ali, Monowar Hossain, Mahfuzul Hassan, and Adeolu Oluremi on this work. His recent publication in 2026 details the design and potential application of these near-infrared-responsive nanomedicines.
Metrics
- Publications: 1
Selected Publications
-
Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
Collaboration Network
Top Collaborators
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
Similar Researchers
Based on overlapping research topics